Financhill
Sell
10

ADN Quote, Financials, Valuation and Earnings

Last price:
$4.16
Seasonality move :
-27.26%
Day range:
$4.06 - $4.69
52-week range:
$1.71 - $9.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.44x
P/B ratio:
2.14x
Volume:
33K
Avg. volume:
172.4K
1-year change:
-53.62%
Market cap:
$11.4M
Revenue:
$4.9M
EPS (TTM):
-$26.25
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- $882.7K $7.1M $7.8M $4.9M
Revenue Growth (YoY) -- -- 700.88% 10.86% -38%
 
Cost of Revenues -- $513.8K $5.4M $8.6M $18.3M
Gross Profit -- $368.8K $1.7M -$744K -$13.4M
Gross Profit Margin -- 41.79% 23.53% -9.49% -276.35%
 
R&D Expenses -- $102.5K $3.5M $9.8M $12.1M
Selling, General & Admin -- $3.5M $41.9M $35.9M $32.5M
Other Inc / (Exp) $4.6M -$41.8K $22.7M -$29.9M -$13.3M
Operating Expenses $696.6K $3.4M $45.8M $45.8M $44M
Operating Income -$696.6K -$3.1M -$44.1M -$46.5M -$57.4M
 
Net Interest Expenses -- $5.5K $51K -- --
EBT. Incl. Unusual Items $3.9M -$3.1M -$21.4M -$76.3M -$70.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1M -- -$923K -$2M $719K
Net Income to Company $2.9M -$3.1M -$20.5M -$74.3M -$71.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.9M -$3.1M -$20.5M -$74.3M -$71.4M
 
Basic EPS (Cont. Ops) $4.20 -$4.50 -$13.50 -$43.28 -$37.24
Diluted EPS (Cont. Ops) $4.20 -$4.50 -$13.50 -$43.28 -$37.24
Weighted Average Basic Share $684K $684K $1.5M $1.7M $1.9M
Weighted Average Diluted Share $684K $684K $1.5M $1.7M $1.9M
 
EBITDA -$696.6K -$3.1M -$42.4M -$42.2M -$53.8M
EBIT -$696.6K -$3.1M -$44.1M -$46.5M -$57.4M
 
Revenue (Reported) -- $882.7K $7.1M $7.8M $4.9M
Operating Income (Reported) -$696.6K -$3.1M -$44.1M -$46.5M -$57.4M
Operating Income (Adjusted) -$696.6K -$3.1M -$44.1M -$46.5M -$57.4M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $200.4K $1M $2.2M $1.1M $805K
Revenue Growth (YoY) -- 400.61% 121.84% -50.02% -27.61%
 
Cost of Revenues $217.9K $669K $2.3M $1.9M $155K
Gross Profit -$17.6K $334K -$45K -$793K $650K
Gross Profit Margin -8.77% 33.3% -2.02% -71.31% 80.75%
 
R&D Expenses -- $639K $2.6M $2.9M $3.6M
Selling, General & Admin $444.1K $6.6M $8M $8.3M $6.4M
Other Inc / (Exp) $98.4K $3.6M -$436K -$10.3M -$2.6M
Operating Expenses $389.3K $7.1M $11.1M $10.7M $9.2M
Operating Income -$406.9K -$6.8M -$11.2M -$11.5M -$8.6M
 
Net Interest Expenses $500 $3K -- -- $54K
EBT. Incl. Unusual Items -$309K -$3.1M -$11.6M -$21.8M -$11.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.1K -- -$439K $4K --
Net Income to Company -- -- -- -$21.8M -$11.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$312.1K -$3.1M -$11.1M -$21.8M -$11.3M
 
Basic EPS (Cont. Ops) -$0.60 -$2.10 -$6.60 -$12.26 -$4.28
Diluted EPS (Cont. Ops) -$0.60 -$2.10 -$6.60 -$12.26 -$4.28
Weighted Average Basic Share $624.6K $1.5M $1.7M $1.8M $2.6M
Weighted Average Diluted Share $624.6K $1.5M $1.7M $1.8M $2.6M
 
EBITDA -$308.5K -$6.8M -$10.4M -$10.5M -$8.2M
EBIT -$308.5K -$6.8M -$11.2M -$11.5M -$8.6M
 
Revenue (Reported) $200.4K $1M $2.2M $1.1M $805K
Operating Income (Reported) -$406.9K -$6.8M -$11.2M -$11.5M -$8.6M
Operating Income (Adjusted) -$308.5K -$6.8M -$11.2M -$11.5M -$8.6M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- $3.1M $8.1M $6.4M $7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $1.2M $8.2M $8.2M $16.1M
Gross Profit -- $1.8M -$119K -$1.7M -$9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $726.9K $7.7M $11M $11.1M
Selling, General & Admin -- $17.3M $45.8M $34.3M $28.9M
Other Inc / (Exp) $98.4K $13.5M $17.1M -$47.6M -$6.1M
Operating Expenses -- $18M $54.5M $43.9M $42.8M
Operating Income -- -$16.2M -$54.6M -$45.6M -$51.9M
 
Net Interest Expenses $500 $15.5K $47K -- $330K
EBT. Incl. Unusual Items -- -$2.7M -$37.5M -$93M -$58.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$3.1K -$2M -$74K -$136K
Net Income to Company -- -- -- -- -$58.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$2.7M -$35.5M -$92.9M -$58.2M
 
Basic EPS (Cont. Ops) -- -$3.00 -$21.30 -$53.39 -$26.25
Diluted EPS (Cont. Ops) -- -$3.30 -$21.30 -$53.39 -$26.25
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -$6.1M -$52.2M -$42.6M -$50.5M
EBIT -- -$6.3M -$54.6M -$45.6M -$51.9M
 
Revenue (Reported) -- $3.1M $8.1M $6.4M $7M
Operating Income (Reported) -- -$16.2M -$54.6M -$45.6M -$51.9M
Operating Income (Adjusted) -- -$6.3M -$54.6M -$45.6M -$51.9M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $200.4K $2.5M $3.5M $2.1M $4.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $217.9K $1M $3.8M $3.4M $1.2M
Gross Profit -$17.6K $1.5M -$306K -$1.3M $3.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $668K $4.8M $6M $5M
Selling, General & Admin $444.1K $14.5M $18.5M $16.8M $13.3M
Other Inc / (Exp) $98.4K $13.5M $7.9M -$9.8M -$2.4M
Operating Expenses $389.3K $15.2M $23.9M $22.1M $21M
Operating Income -$406.9K -$13.7M -$24.3M -$23.4M -$18M
 
Net Interest Expenses $500 $13K $10K -- $286K
EBT. Incl. Unusual Items -$309K -$237K -$16.3M -$33M -$20.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.1K -- -$1.1M $800K -$55K
Net Income to Company -- -- -- -$33.8M -$20.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$312.1K -$237K -$15.2M -$33.8M -$20.6M
 
Basic EPS (Cont. Ops) -$0.60 $0.30 -$9.00 -$19.19 -$7.91
Diluted EPS (Cont. Ops) -$0.60 -- -$9.00 -$19.19 -$7.91
Weighted Average Basic Share $624.6K $2.8M $3.4M $3.5M $5.2M
Weighted Average Diluted Share $624.6K $2.9M $3.4M $3.5M $5.2M
 
EBITDA -$308.5K -$3.7M -$22.8M -$21.7M -$16.8M
EBIT -$308.5K -$3.9M -$24.3M -$23.4M -$18M
 
Revenue (Reported) $200.4K $2.5M $3.5M $2.1M $4.3M
Operating Income (Reported) -$406.9K -$13.7M -$24.3M -$23.4M -$18M
Operating Income (Adjusted) -$308.5K -$3.9M -$24.3M -$23.4M -$18M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $520.4K $515.7K $79.8M $32.9M $3.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $421.1K $3.1M $979K $191K
Inventory -- $107.9K $7M $12.6M $2.7M
Prepaid Expenses -- $1.7K $1.1M $688K $1.1M
Other Current Assets $57.1K $24.5K $298K $121K $10K
Total Current Assets $577.5K $1.7M $97.4M $49.5M $8.8M
 
Property Plant And Equipment -- $198.7K $8.6M $22M $24.8M
Long-Term Investments -- -- -- $320K --
Goodwill -- -- $30M $5.7M --
Other Intangibles -- -- $23.3M $6.1M $79K
Other Long-Term Assets $225.4M $140 $2.5M $6M $1.1M
Total Assets $226M $1.9M $163M $89.6M $34.7M
 
Accounts Payable $25.5K $881.4K $4.8M $4.7M $5.1M
Accrued Expenses $25K $815K $5.9M $1.5M $831K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $2.3M $2.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.3M $3.4M $18.9M $13.7M $11.9M
 
Long-Term Debt -- $42.8K -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $221M $3.7M $32.8M $25.4M $21.3M
 
Common Stock $670 $2.5K $5K $5K $8K
Other Common Equity Adj -- $111.8K -$1.3M -$2.6M -$2.3M
Common Equity $5M -$1.8M $130.2M $64.1M $13.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $5M -$1.8M $130.2M $64.1M $13.4M
 
Total Liabilities and Equity $226M $1.9M $163M $89.6M $34.7M
Cash and Short Terms $520.4K $515.7K $79.8M $32.9M $3.6M
Total Debt -- $42.8K -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- $116.1M $46.5M $10.1M $682K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $1.1M $2.6M $1M $922K
Inventory -- $857.7K $10.2M $15.2M $2M
Prepaid Expenses -- $1.8M -- $1.2M $1.8M
Other Current Assets -- $660.5K $10.7M $43K $9K
Total Current Assets -- $121.4M $71M $31.5M $6.9M
 
Property Plant And Equipment -- $1.1M $9.6M $24.3M $7.1M
Long-Term Investments -- -- $311K $326K --
Goodwill -- -- $30M -- --
Other Intangibles -- -- $22M $1.9M $76K
Other Long-Term Assets -- $2.7M $2.7M $5.9M $303K
Total Assets -- $130.4M $137.4M $63.9M $14.4M
 
Accounts Payable -- $2.9M $4.9M $6.5M $6.3M
Accrued Expenses -- $331.1K $1.5M $1M $716K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $2.4M $162K
Other Current Liabilities -- -- -- -- $5.2M
Total Current Liabilities -- $3.6M $13.8M $13.4M $15.8M
 
Long-Term Debt -- -- -- -- $537K
Capital Leases -- -- -- -- --
Total Liabilities -- $23.7M $19.2M $23.8M $17.2M
 
Common Stock -- $4.6K $5K $6K --
Other Common Equity Adj -- -$176.5K -$3.1M -$2.3M -$2.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $106.7M $118.2M $40.1M -$2.9M
 
Total Liabilities and Equity -- $130.4M $137.4M $63.9M $14.4M
Cash and Short Terms -- $116.1M $46.5M $10.1M $682K
Total Debt -- -- -- -- $537K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.9M -$3.1M -$20.5M -$74.3M -$71.4M
Depreciation & Amoritzation -- $22.5K $1.7M $4.3M $3.6M
Stock-Based Compensation -- $869.5K $7.7M $10.4M $9.9M
Change in Accounts Receivable -- -$206.4K -$305K $2.5M $662K
Change in Inventories -- -$75.5K -$1.6M -$5.9M -$1.8M
Cash From Operations -$630.9K -$1.4M -$35.8M -$32.1M -$32.1M
 
Capital Expenditures -- $122.5K $6.1M $14.2M $4.6M
Cash Acquisitions -- -- -$19.4M -- -$1.9M
Cash From Investing $265.1K -$122.5K -$25.6M -$14.5M -$6.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $118K -- --
Long-Term Debt Repaid -- -$500K -- -$40K --
Repurchase of Common Stock -- -$69.4K -- -- --
Other Financing Activities -- -- $141.1M -- --
Cash From Financing -- $882.3K $141.5M -$40K $9.1M
 
Beginning Cash (CF) $886.3K $1.2M $516K $79.8M $33.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$365.9K -$665.3K $80.1M -$46.7M -$29.3M
Ending Cash (CF) $520.4K $515.7K $79.8M $33.6M $4.4M
 
Levered Free Cash Flow -$630.9K -$1.5M -$42M -$46.3M -$36.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -$21.8M -$11.3M
Depreciation & Amoritzation -- -- -- $997K $400K
Stock-Based Compensation -- -- -- $2.3M $2.1M
Change in Accounts Receivable -- -- -- -$340K $310K
Change in Inventories -- -- -- -$330K $74K
Cash From Operations -- -$4M -$10M -$7.5M -$1.9M
 
Capital Expenditures -- $3.4M $1.8M $1.7M -$1K
Cash Acquisitions -- -$1.9M -- -$1.9M --
Cash From Investing -- -$5.3M -$2.1M -$3.5M $301K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $117K -- -- $540K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $428K -- -- --
Cash From Financing -- $807K -- $3.4M $696K
 
Beginning Cash (CF) -- $125M $59.3M $20.3M $1.6M
Foreign Exchange Rate Adjustment -- -$291K -$589K $83K -$3K
Additions / Reductions -- -$8.6M -$12.2M -$7.6M -$937K
Ending Cash (CF) -- $116.1M $46.5M $12.8M $682K
 
Levered Free Cash Flow -- -$7.4M -$11.8M -$9.1M -$1.9M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -- -$58.2M
Depreciation & Amoritzation -- -- -- -- $3.1M
Stock-Based Compensation -- -- -- $4.9M $9M
Change in Accounts Receivable -- -- -- -- $203K
Change in Inventories -- -- -- -- $917K
Cash From Operations -- -- -$49M -$21.7M -$18M
 
Capital Expenditures -- $3.5M $5.5M $15M $1.1M
Cash Acquisitions -- -$5.9M -$13.5M -$1.9M --
Cash From Investing -- -- -$19.3M -$16.8M -$536K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $3.4M $6.5M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$68.2M -$35.1M -$12.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$54.4M -$36.6M -$19.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -$33.8M -$20.6M
Depreciation & Amoritzation -- -- -- $1.6M $1.1M
Stock-Based Compensation -- -- -- $4.9M $4M
Change in Accounts Receivable -- -- -- -$118K -$577K
Change in Inventories -- -- -- -$2.3M $422K
Cash From Operations -- -$16.2M -$29.4M -$18.9M -$4.8M
 
Capital Expenditures -- $3.5M $2.8M $3.6M $28K
Cash Acquisitions -- -$5.9M -- -$1.9M --
Cash From Investing -- -$9.4M -$3.1M -$5.4M $272K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $117K -- -- $540K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $141.1M -- -- --
Cash From Financing -- $141.5M -- $3.4M $822K
 
Beginning Cash (CF) -- $125.5M $139M $53.9M $6M
Foreign Exchange Rate Adjustment -- -$276K -$750K $94K -$14K
Additions / Reductions -- $115.9M -$32.5M -$20.9M -$3.7M
Ending Cash (CF) -- $241.1M $105.8M $33.1M $2.3M
 
Levered Free Cash Flow -- -$19.7M -$32.2M -$22.5M -$4.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock